ScoreWhy is Sino Medical Sciences Technology, Inc. ?
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of 3.76% and Operating profit at -164.37% over the last 5 years
3
Positive results in Mar 25
- OPERATING CASH FLOW(Y) Highest at CNY 144.59 MM
- NET PROFIT(Q) At CNY 2.97 MM has Grown at 544.24%
- NET SALES(HY) At CNY 238.31 MM has Grown at 26.54%
4
With ROE of -0.06%, it has a risky valuation with a 8.83 Price to Book Value
- Over the past year, while the stock has generated a return of 62.33%, its profits have risen by 95.5%
5
Market Beating Performance
- The stock has generated a return of 62.33% in the last 1 year, much higher than market (China Shanghai Composite) returns of 14.77%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sino Medical Sciences Technology, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sino Medical Sciences Technology, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sino Medical Sciences Technology, Inc.
62.33%
1.09
70.08%
China Shanghai Composite
14.77%
1.01
14.58%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.76%
EBIT Growth (5y)
-164.37%
EBIT to Interest (avg)
-61.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.36
Tax Ratio
50.89%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.83
EV to EBIT
-896.74
EV to EBITDA
84.56
EV to Capital Employed
9.84
EV to Sales
16.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.10%
ROE (Latest)
-0.06%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend29What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 144.59 MM
NET PROFIT(Q)
At CNY 2.97 MM has Grown at 544.24%
NET SALES(HY)
At CNY 238.31 MM has Grown at 26.54%
ROCE(HY)
Highest at 0.23%
INVENTORY TURNOVER RATIO(HY)
Highest at 2.09%
DEBTORS TURNOVER RATIO(HY)
Highest at 18.17%
RAW MATERIAL COST(Y)
Fallen by -9.75% (YoY
PRE-TAX PROFIT(Q)
Highest at CNY 4.25 MM
-9What is not working for the Company
INTEREST(HY)
At CNY 2.74 MM has Grown at 5.68%
NET SALES(Q)
At CNY 99.65 MM has Fallen at -12.42%
OPERATING PROFIT(Q)
Lowest at CNY -1.35 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -1.36 %
Here's what is working for Sino Medical Sciences Technology, Inc.
Net Profit
At CNY 2.97 MM has Grown at 544.24%
over average net sales of the previous four periods of CNY -0.67 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 144.59 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Pre-Tax Profit
At CNY 4.25 MM has Grown at 163.51%
over average net sales of the previous four periods of CNY -6.69 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Inventory Turnover Ratio
Highest at 2.09% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 18.17% and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Pre-Tax Profit
Highest at CNY 4.25 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Raw Material Cost
Fallen by -9.75% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Sino Medical Sciences Technology, Inc.
Net Sales
At CNY 99.65 MM has Fallen at -12.42%
over average net sales of the previous four periods of CNY 113.77 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Interest
At CNY 2.74 MM has Grown at 5.68%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Profit
Lowest at CNY -1.35 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -1.36 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
